Products
Azur's portfolio comprises FazaClo®, Gastrocrom®, women's health products and urology products. FazaClo is an antipsychotic drug indicated for the management of severely ill schizophrenic patients who fail to respond to standard treatments. FazaClo also is indicated for reduction in the risk of recurrent suicidal behaviour in schizophrenia or schizoaffective disorders. Gastrocrom is indicated for the management of patients with mastocytosis. Azur’s remaining portfolio consists of thirteen prescription products focussed in the prenatal vitamin and urology areas.
